Cinemark Holdings Inc's stock rose by 3.11% and reached a 20-day high amid positive market conditions.
Mike Hickey from Benchmark & Co reiterated his positive outlook on Cinemark, assigning a Buy rating with a $35 price target, implying over 55% upside for investors. This reflects strong market confidence in the stock, supported by ongoing industry tailwinds from the Warner Bros. and Discovery sale process, which is expected to enhance the volume of films and stabilize traditional theater windows. Additionally, Cinemark's management is executing a share repurchase program, signaling confidence in the business outlook.
The optimistic rating and share repurchase program could attract more investor interest, indicating a favorable outlook for Cinemark's future performance.
Wall Street analysts forecast CNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNK is 33.67 USD with a low forecast of 28.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast CNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNK is 33.67 USD with a low forecast of 28.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 23.230
Low
28.00
Averages
33.67
High
37.00
Current: 23.230
Low
28.00
Averages
33.67
High
37.00
B. Riley
Drew Crum
Neutral
downgrade
$35 -> $29
2026-01-22
Reason
B. Riley
Drew Crum
Price Target
$35 -> $29
AI Analysis
2026-01-22
downgrade
Neutral
Reason
B. Riley analyst Drew Crum lowered the firm's price target on Cinemark (CNK) to $29 from $35 and keeps a Neutral rating on the shares. The firm reviewed 4Q25 and previews exhibitor earnings with a slightly more subdued but still positive outlook following a weak holiday box office, a reassessed film slate, and potential valuation pressure from Warner Bros. Discovery (WBD)-related developments, the analyst tells investors in a research note.
JPMorgan
Overweight
to
NULL
downgrade
$37 -> $31
2026-01-22
Reason
JPMorgan
Price Target
$37 -> $31
2026-01-22
downgrade
Overweight
to
NULL
Reason
JPMorgan lowered the firm's price target on Cinemark to $31 from $37 and keeps an Overweight rating on the shares. The firm updated the company's model ahead of the Q4 report. JPMorgan reduced its 2026 North America box office revenue estimate to $9.57B from $9.75B.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CNK
Unlock Now
MoffettNathanson
Robert Fishman
Neutral -> Buy
upgrade
$30
2026-01-20
Reason
MoffettNathanson
Robert Fishman
Price Target
$30
2026-01-20
upgrade
Neutral -> Buy
Reason
MoffettNathanson analyst Robert Fishman upgraded Cinemark to Buy from Neutral with a $30 price target. After comparing the top of the 2026 film slate to 2025, the firm concludes that the upcoming year is "stronger on most dimensions," adding that Cinemark is priced at an attractive entry point with a much improved balance sheet.
Morgan Stanley
Benjamin Swinburne
Overweight -> Equal Weight
downgrade
$35 -> $28
2025-12-18
Reason
Morgan Stanley
Benjamin Swinburne
Price Target
$35 -> $28
2025-12-18
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley analyst Benjamin Swinburne downgraded Cinemark to Equal Weight from Overweight with a price target of $28, down from $35.
About CNK
Cinemark Holdings, Inc. is a movie theatre company. The Company is engaged in the motion picture exhibition industry, with theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. Its circuit, comprised of various brands that also include Century, Tinseltown and Rave, operates approximately 497 theaters with 5,653 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as concert, sporting and gaming events, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
